# DARE (Dare Bioscience, Inc.) - SEC EDGAR Financial Statements

> Dare Bioscience, Inc. reported $1.41M in revenue and a net loss of $10.58M for the trailing twelve months ended September 30, 2026 (up 2005.6% year over year), with a 26.4% gross margin and a -746.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/DARE
- Markdown: https://convexityos.com/fundamentals/DARE.md
- SEC CIK: 0001401914
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:06 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001401914&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $1.41M | +2005.6% YoY |
| Operating Income | TTM | -$10.53M | -746.1% margin |
| Net Income | TTM | -$10.58M | -749.8% net margin |
| Diluted EPS | TTM | -$0.61 | Split-adjusted |
| Free Cash Flow | TTM | -$18.05M | -1279.2% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $11.53M | Total debt: $869K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.03M | $9.8K | $2.81M | $10.00M | $0 | -- | -- | -- | -- | $766K |
| Cost of Revenue | $296K | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | $734K | $9.8K | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | $5.52M | $14.31M | $21.54M | $30.04M | $30.62M | $20.77M | $8.55M | $6.41M | $985K | $73K |
| Selling, General & Admin | $8.76M | $9.16M | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | $14.29M | $23.46M | $33.75M | $41.39M | $39.07M | $27.40M | $14.34M | $16.88M | $11.18M | $631K |
| **Operating Income** | -$13.55M | -$23.45M | -$30.94M | -$31.39M | -$39.07M | -$27.40M | -$14.34M | -$16.88M | -$11.18M | -$631K |
| **EBITDA** | -$11.92M | -$23.41M | -$30.90M | -$31.36M | -$39.04M | -$27.36M | -$14.33M | -$16.88M | -$11.18M | -$370K |
| Interest Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $86K |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | $323K | $42K |
| Income Before Tax | -$13.54M | -$4.05M | -$30.16M | -$30.95M | -$38.70M | -$27.40M | -$14.26M | -$16.81M | -$11.52M | -$673K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.2K | $0 | -- |
| **Net Income** | -$13.40M | -$4.05M | -$30.16M | -$30.95M | -$38.70M | -$27.40M | -$14.26M | -$16.74M | -$11.50M | -$673K |
| Basic EPS | -$1.20 | -$0.48 | -$4.15 | -$4.44 | -$7.56 | -$10.92 | -$11.64 | -$188.48 | $427.37 | -$97.24 |
| **Diluted EPS** | -$1.20 | -$0.48 | -$4.15 | -$4.44 | -$7.56 | -$10.92 | -$11.64 | -$188.48 | $427.37 | -$97.24 |
| Basic Shares Outstanding | 11.2M | 8.5M | 7.3M | 7.0M | 5.1M | 2.5M | 1.3M | 89.4K | 26.9K | 7.0K |
| Diluted Shares Outstanding | 11.2M | 8.5M | 7.3M | 7.0M | 5.1M | 2.5M | 1.3M | 89.4K | 26.9K | 7.0K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $48K | $188K | $152K | $1.02M | $2.3K | -$21K | $25K | -$64K |
| Cost of Revenue | $180K | $320K | $242K | $296K | $0 | $0 | $0 | -- |
| **Gross Profit** | -$133K | -$132K | -$90K | $728K | $2.3K | -$21K | $25K | -- |
| Research & Development | $319K | $242K | $660K | $622K | $1.18M | $1.43M | $2.30M | $3.34M |
| Selling, General & Admin | $2.64M | $2.59M | $2.25M | $1.58M | $2.50M | $2.38M | $2.31M | -- |
| Total Operating Expenses | $2.96M | $2.84M | $2.91M | $2.20M | $3.67M | $3.81M | $4.61M | $5.32M |
| **Operating Income** | -$3.09M | -$2.97M | -$3.00M | -$1.47M | -$3.67M | -$3.83M | -$4.58M | -$5.39M |
| **EBITDA** | -$2.58M | -$2.40M | -$2.44M | -$937K | -$3.20M | -$3.37M | -$4.41M | -$5.38M |
| **Net Income** | -$3.16M | -$2.98M | -$3.00M | -$1.44M | -$3.56M | -$4.02M | -$4.38M | -$5.51M |
| Basic EPS | -$0.18 | -$0.20 | -$0.21 | -- | -$0.28 | -$0.45 | -$0.50 | -- |
| **Diluted EPS** | -$0.18 | -$0.20 | -$0.21 | -- | -$0.28 | -$0.45 | -$0.50 | -- |
| Basic Shares Outstanding | 17.4M | 14.9M | 14.5M | -- | 12.8M | 8.9M | 8.8M | -- |
| Diluted Shares Outstanding | 17.4M | 14.9M | 14.5M | -- | 12.8M | 8.9M | 8.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $24.71M | $15.70M | $10.48M | $34.67M | $51.67M | $4.67M | $4.78M | $6.81M | $7.56M | $45K |
| **Cash & Short-Term Investments** | $24.71M | $15.70M | $10.48M | $34.67M | $51.67M | $4.67M | $4.78M | $6.81M | $7.56M | $45K |
| Accounts Receivable, Net | -- | -- | -- | -- | $0 | -- | -- | -- | -- | $823K |
| Other Current Assets | $573K | $0 | $0 | $0 | -- | -- | -- | $0 | $193K | -- |
| **Total Current Assets** | $27.06M | $18.45M | $17.54M | $43.04M | $55.30M | $6.98M | $6.44M | $7.24M | $8.35M | $45K |
| Property, Plant & Equipment, Net | $1.56M | $1.34M | $656K | $65K | $26K | $38K | $64K | $9.4K | $0 | $668K |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | $0 | $5.20M | -- |
| Other Non-Current Assets | $1.01M | $1.11M | $600K | $254K | $485K | $529K | $935K | $578K | $723K | $13K |
| **Total Non-Current Assets** | $5.41M | $3.65M | $3.74M | $788K | $511K | $567K | $999K | $587K | $5.91M | $0 |
| **Total Assets** | $32.47M | $22.10M | $21.28M | $43.83M | $55.81M | $7.55M | $7.44M | $7.83M | $14.26M | $45K |
| Accounts Payable | $1.20M | $1.46M | $3.39M | $2.03M | $2.10M | $1.02M | $1.08M | $460K | $308K | $1.45M |
| Short-Term Debt | -- | $4.1K | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Current) | -- | -- | -- | $0 | -- | -- | -- | -- | -- | $2.50M |
| **Total Current Liabilities** | $23.69M | $21.61M | $20.48M | $31.62M | $16.05M | $7.66M | $5.61M | $1.09M | $967K | $755K |
| Deferred Revenue (Non-Current) | $0 | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M | $0 | -- | -- | $1.99M |
| Other Non-Current Liabilities | -- | -- | -- | -- | $0 | $42K | $390K | $9.7K | -- | $1.21M |
| **Total Non-Current Liabilities** | $5.95M | $6.50M | $5.85M | $1.09M | $1.00M | $1.04M | $1.39M | $9.7K | $392 | $7.64M |
| **Total Liabilities** | $29.63M | $28.11M | $26.33M | $32.71M | $17.05M | $8.70M | $7.00M | $1.10M | $967K | $755K |
| **Total Debt (incl. Leases)** | $2.66M | $1.31M | $1.41M | $489K | $270K | $389K | $800K | $389K | -- | -- |
| Common Stock | $1.4K | $870 | $833 | $8.5K | $8.4K | $4.2K | $2.0K | $1.1K | $605 | $91 |
| Retained Earnings | -$188.7M | -$175.3M | -$171.2M | -$141.1M | -$110.1M | -$71.43M | -$44.02M | -$28.97M | -$12.23M | -$728K |
| Accumulated Other Comp. Income | -$422K | -$429K | -$361K | -$351K | -$155K | -$91K | -$103K | -$97K | -$18K | -- |
| **Total Stockholders' Equity** | $2.84M | -$6.01M | -$5.05M | $11.11M | $38.75M | -$1.15M | $441K | $6.73M | $13.29M | -$711K |
| Total Equity | $2.84M | -$6.01M | -$5.05M | $11.11M | $38.75M | -$1.15M | $441K | $6.73M | $13.29M | -$711K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $11.53M | $12.62M | $18.52M | $24.71M | $23.08M | $5.04M | $10.33M | $15.70M |
| **Cash & Short-Term Investments** | $11.53M | $12.62M | $18.52M | $24.71M | $23.08M | $5.04M | $10.33M | $15.70M |
| Other Current Assets | $1.19M | $456K | $688K | $573K | $53K | -- | -- | $0 |
| **Total Current Assets** | $16.92M | $16.69M | $21.66M | $27.06M | $25.00M | $6.60M | $11.82M | $18.45M |
| Property, Plant & Equipment, Net | $1.51M | $1.42M | $1.45M | $1.56M | $1.66M | $1.65M | $1.48M | $1.34M |
| Other Non-Current Assets | $2.52M | $2.55M | $2.44M | $1.01M | $1.02M | $1.07M | $1.08M | $1.11M |
| **Total Non-Current Assets** | $5.17M | $5.68M | $6.17M | $5.41M | $5.74M | $6.38M | $6.80M | $3.65M |
| **Total Assets** | $22.10M | $22.37M | $27.83M | $32.47M | $30.75M | $12.98M | $18.62M | $22.10M |
| Accounts Payable | $779K | $763K | $1.23M | $1.20M | $1.84M | $1.76M | $1.88M | $1.46M |
| Short-Term Debt | -- | -- | -- | -- | $11K | $188K | $92K | $4.1K |
| **Total Current Liabilities** | $13.71M | $16.92M | $21.12M | $23.69M | $21.22M | $19.22M | $21.19M | $21.61M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $1.00M | $1.00M | $1.00M | $1.00M |
| **Total Non-Current Liabilities** | $6.04M | $6.01M | $5.97M | $5.95M | $6.67M | $6.49M | $6.99M | $6.50M |
| **Total Liabilities** | $19.76M | $22.93M | $27.09M | $29.63M | $27.89M | $25.71M | $28.18M | $28.11M |
| **Total Debt (incl. Leases)** | $869K | $1.02M | $1.61M | $2.66M | $2.94M | $3.22M | $3.66M | $1.31M |
| Common Stock | $2.0K | $1.5K | $1.5K | $1.4K | $1.4K | $903 | $885 | $870 |
| Retained Earnings | -$197.8M | -$194.7M | -$191.7M | -$188.7M | -$187.2M | -$183.7M | -$179.7M | -$175.3M |
| Accumulated Other Comp. Income | -$368K | -$375K | -$377K | -$422K | -$396K | -$403K | -$416K | -$429K |
| **Total Stockholders' Equity** | $2.34M | -$560K | $734K | $2.84M | $2.86M | -$12.73M | -$9.56M | -$6.01M |
| Total Equity | $2.34M | -$560K | $734K | $2.84M | $2.86M | -$12.73M | -$9.56M | -$6.01M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$13.40M | -$4.05M | -$30.16M | -$30.95M | -$38.70M | -$27.40M | -$14.26M | -$16.74M | -$11.50M | -$673K |
| Depreciation & Amortization | $1.63M | $42K | $38K | $24K | $26K | $43K | $11K | $2.4K | $0 | $261K |
| Stock-Based Compensation | $1.50M | $2.20M | $2.53M | $2.16M | $1.60M | $742K | $462K | $139K | $16K | $9.0K |
| Change in Receivables | -$12K | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Change in Payables | -$255K | -$1.93M | $1.36M | -$75K | $1.08M | -$62K | $609K | $151K | $218K | -$603K |
| **Operating Cash Flow** | -$9.89M | $5.47M | -$38.86M | -$18.09M | -$28.76M | -$25.23M | -$13.32M | -$10.27M | -$2.54M | -$372K |
| Capital Expenditure | -$385K | -$573K | -$629K | -$63K | -$15K | -$18K | $0 | -$12K | $0 | -$535K |
| **Free Cash Flow** | -$10.27M | $4.90M | -$39.49M | -$18.15M | -$28.78M | -$25.25M | -$13.32M | -$10.28M | -$2.54M | -$907K |
| **Investing Cash Flow** | -$385K | -$573K | -$629K | -$63K | -$15K | -$18K | $6.14M | -$519K | $9.92M | -$418K |
| Common Stock Issued | $20.93M | $454K | -- | $1.30M | $16.30M | $22.98M | $5.15M | -- | -- | $918K |
| **Financing Cash Flow** | $19.28M | $355K | $15.64M | $1.34M | $75.85M | $25.13M | $5.15M | $10.11M | $155K | $198K |
| **Net Change in Cash** | $9.01M | $5.19M | -$23.86M | -$17.00M | $47.00M | -$111K | -$2.03M | -$754K | $7.52M | -$175K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.16M | -$2.98M | -$3.00M | -$1.44M | -$3.56M | -$4.02M | -$4.38M | -$5.51M |
| Depreciation & Amortization | $511K | $572K | $555K | $534K | $470K | $454K | $176K | $6.4K |
| Stock-Based Compensation | $450K | $287K | $455K | $357K | $403K | $359K | $377K | $489K |
| Change in Receivables | -$23K | $124K | -$121K | -$12K | $0 | $0 | $0 | -- |
| **Operating Cash Flow** | -$6.85M | -$6.78M | -$5.52M | $1.58M | -$578K | -$5.42M | -$5.47M | $5.31M |
| Capital Expenditure | -$202K | -$81K | $0 | -$207K | -$175K | $153K | -$157K | -$563K |
| **Free Cash Flow** | -$7.05M | -$6.86M | -$5.52M | $1.37M | -$753K | -$5.26M | -$5.63M | $4.74M |
| **Investing Cash Flow** | -$202K | -$81K | $0 | -$207K | -$175K | $153K | -$157K | -$563K |
| Common Stock Issued | $253K | $167K | $95K | $1.14M | $18.88M | $475K | $436K | -- |
| **Financing Cash Flow** | $5.96M | $951K | -$715K | $288K | $18.79M | -$44K | $247K | -$211K |
| **Net Change in Cash** | -$1.09M | -$5.90M | -$6.19M | $1.64M | $18.04M | -$5.29M | -$5.37M | $4.47M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 71.3% | 100.0% | -- | -- | -- | -- | -- | -- | -- | -- |
| **Operating Margin** | -1315.5% | -239692.2% | -1101.9% | -313.9% | -- | -- | -- | -- | -- | -82.3% |
| **Net Profit Margin** | -1300.7% | -41430.9% | -1074.2% | -309.5% | -- | -- | -- | -- | -- | -87.8% |
| Return on Equity (ROE) | -471.4% | -- | -- | -278.5% | -99.8% | -- | -3235.7% | -248.8% | -86.5% | -- |
| Return on Assets (ROA) | -41.3% | -18.3% | -141.7% | -70.6% | -69.3% | -362.9% | -191.6% | -213.8% | -80.7% | -1507.8% |
| Current Ratio | 1.14x | 0.85x | 0.86x | 1.36x | 3.44x | 0.91x | 1.15x | 6.64x | 8.64x | 0.06x |
| Quick Ratio | 1.04x | 0.73x | 0.51x | 1.10x | 3.22x | 0.61x | 0.85x | 6.24x | 7.82x | 1.15x |
| Debt to Equity | 0.93x | -- | -- | 0.04x | 0.01x | -- | 1.81x | 0.06x | -- | -- |
| **Revenue Growth (YoY)** | +10429.4% | -99.7% | -71.9% | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +7406.1% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -144.1% | -- | -- |
| Operating Cash Flow Growth (YoY) | -280.6% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -309.6% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -- | -- | -- | -- | -100.0% | -- | -- | -- | -- | -- |
| 10Y Revenue / Share Growth | -- | -100.0% | -96.3% | -99.9% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 26.4% | 37.2% | 53.5% | 71.3% | -- | -- | -- | -- |
| **Operating Margin** | -746.1% | -813.4% | -1034.4% | -1315.5% | -- | -- | -84951.7% | -239692.2% |
| **Net Profit Margin** | -749.8% | -804.4% | -1038.8% | -1300.7% | -- | -- | -6470.9% | -41430.9% |
| Return on Equity (ROE) | -452.0% | -- | -1636.7% | -471.4% | -611.1% | -- | -- | -- |
| Return on Assets (ROA) | -47.9% | -49.1% | -43.2% | -41.3% | -56.8% | -143.3% | -9.0% | -18.3% |
| Current Ratio | 1.23x | 0.99x | 1.03x | 1.14x | 1.18x | 0.34x | 0.56x | 0.85x |
| Quick Ratio | 0.84x | 0.75x | 0.88x | 1.04x | 1.09x | 0.26x | 0.49x | 0.73x |
| Debt to Equity | 0.37x | -- | 2.20x | 0.93x | 1.03x | -- | -- | -- |
| **Revenue Growth (YoY)** | +2005.6% | -- | +499.6% | -- | -94.6% | -194.4% | +173.3% | -103.5% |
| Gross Profit Growth (YoY) | -5973.2% | -- | -453.4% | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -131.1% | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -129.4% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -70.2% | -- | -142.0% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -71.0% | -- | -141.7% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
